Cerus (STU:CU2) Ending Cash Position: €16.2 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:CU2 Cerus Corp STU:CU2
78 GF Score
Price €2.34
GF Value €1.97
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Cerus Ending Cash Position?

Cerus STU:CU2 +0.86% 78 Ending Cash Position is €16.2 Mil as of Jun. 2026. GuruFocus rates STU:CU2 with a GF Score™ of 78/100 and a GF Value™ of €1.97 (Modestly Overvalued). The stock has 3 warning signs investors should review.

Cerus's Ending Cash Position for the quarter that ended in Jun. 2026 was €16.2 Mil.

Cerus's quarterly Ending Cash Position increased from Dec. 2025 (€17.6 Mil) to Mar. 2026 (€24.6 Mil) but then declined from Mar. 2026 (€24.6 Mil) to Jun. 2026 (€16.2 Mil).

Cerus's annual Ending Cash Position increased from Dec. 2023 (€12.3 Mil) to Dec. 2024 (€20.4 Mil) but then declined from Dec. 2024 (€20.4 Mil) to Dec. 2025 (€17.6 Mil).

Cerus Ending Cash Position Related Terms

Cerus Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Cerus's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cerus Ending Cash Position Chart

Cerus Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 45.17 35.27 12.25 20.40 17.59

Cerus Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.85 14.32 17.59 24.64 16.15
STU:CU2
78GF Score
Cerus Corp STU:CU2
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cerus Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Cerus's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=18.242+-0.65
=17.6

Cerus's Ending Cash Position for the quarter that ended in Jun. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=24.722+-8.571
=16.2

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of €16.2 Mil mean?
Cerus (STU:CU2) has a Ending Cash Position of €16.2 Mil as of Jun. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Cerus and its competitors.
Is Cerus' Ending Cash Position too high?
Cerus' current Ending Cash Position is €16.2 Mil. Overall, Cerus has a GF Score™ of 78/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cerus' Ending Cash Position compare to CTKB and TCMD?
Cerus' Ending Cash Position of €16.2 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Medical Devices & Instruments company?
A good Ending Cash Position depends on the Medical Devices & Instruments industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Cerus and its competitors. Cerus's current Ending Cash Position is €16.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cerus stock overvalued right now?
Based on GuruFocus' analysis, Cerus (STU:CU2) is currently considered Modestly Overvalued. The stock's GF Value™ is €1.97, compared to a current price of €2.34 — trading 18.8% above its estimated fair value. The current Ending Cash Position is €16.2 Mil. Cerus' overall GF Score™ is 78/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Cerus (STU:CU2), the current Ending Cash Position is €16.2 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cerus (STU:CU2) Overvalued in 2026?

Based on GuruFocus' analysis, Cerus stock appears to be overvalued. The current stock price of €2.34 is trading 18.8% above its estimated GF Value™ of €1.97. GuruFocus considers Cerus to be Modestly Overvalued.

Key valuation signals for STU:CU2:

  • Ending Cash Position: €16.2 Mil
  • GF Value™: €1.97 vs. price of €2.34 (18.8% above fair value)
  • GF Score™: 78/100 with 3 warning signs

No single metric tells the full story. See the STU:CU2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cerus Business Description

Other Exchanges CERS:USA
Address 1220 Concord Avenue, Suite 600, Concord, CA, USA, 94520
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety, and generates revenue from the same.
78GF Score

Get the complete analysis for STU:CU2

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.34
Price
€1.97
GF Value